Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matthew Young
Observed names:
M. Young,
M.R. Young,
M.R.A. Young
Institutions:
Queen Mary University of London,
Cancer Research UK,
Barts Cancer Institute
Observed institutions:
Queen Mary University of London,
Cancer Research UK,
Belfast City Hospital,
Johns Hopkins Hospital,
Barts Cancer Institute
ORCID:
0000-0002-9775-1956
Observed ORCID:
0000-0002-9775-1956
OpenAlex ID:
A5075573004
Clinical Response to an Oral Prostaglandin Analogue in Patients with Interstitial Cystitis
1998
·
J.D. Kelly
, M.R.A. Young
, et al.
·
European Urology
·
33
Urothelial carcinoma in bladder diverticula: A multicenter analysis of characteristics and treatment outcome in 110 patients
2018
·
C. Voskuilen
, R. Seiler
, et al.
·
European Urology Supplements
·
2
Pegargiminase Suppresses the Fanconi Anemia Pathway and Promotes Melphalan‐Induced DNA Double‐Strand Breaks in Uveal Melanoma
2026
·
Iuliia Pavlyk
, George Field
, et al.
·
Pigment Cell & Melanoma Research
Characteristics of Patients With Advanced or Metastatic Urothelial Cancer Unable to Complete Six Cycles Chemotherapy
2026
·
Francesca Jackson‐Spence
, Domiziana Aspden
, et al.
·
Cancer Medicine
Abstract CT139: Germline HFE mutations predict for durable response to arginine depletion with pegargiminase-based chemotherapy in pleural mesothelioma
2026
·
Peter Wojciech Szlosarek
, George Field
, et al.
·
Cancer Research
Mp41-14 Urothelial Carcinoma in Bladder Diverticula: a Multicenter Analysis of Characteristics and Treatment Outcome
2018
·
Charlotte Voskuilen
, Roland Seiler
, et al.
·
The Journal of Urology
PDF
Abstract No. 189: Chemoembolization of Hepatocellular Carcinoma with a Standardized Treatment and Follow-Up Protocol: Survival, Clinical and Tumor Control Outcome Over 12 Years at a US Center
2009
·
M.R. Young
, J.H. Geschwind
, et al.
·
Journal of Vascular and Interventional Radiology
PDF
Show more works
View as search
Works count:
7
Citation count:
35
H-index:
2
I10-index:
1
Year
Topic
Type